Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-10-092319
Filing Date
2010-10-08
Accepted
2010-10-08 15:56:24
Documents
3
Effectiveness Date
2010-10-08

Document Format Files

Seq Description Document Type Size
1 FORM 8-K c06751e8vk.htm DEFA14A 10863
2 EXHIBIT 99.1 c06751exv99w1.htm EX-99.1 7351
3 GRAPHIC c06751p0669301.jpg GRAPHIC 13466
  Complete submission text file 0000950123-10-092319.txt   38466
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50626 | Film No.: 101116163
SIC: 2834 Pharmaceutical Preparations